[Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome]
Aim:
To study effects of antihypertensive therapy with bisoprolol and actovegin on cerebral perfusion in patients with metabolic syndrome.
Material And Methods:
Thirty patients (18 women and 12 men) with metabolic syndrome and mild arterial hypertension took bisoprolol alone in a dose 5-10 mg/day, and fifteen patients received combined therapy (bisoprolol and actovegin) for 12 weeks. Before the study and 12 weeks later measurements were made of carbohydrate and lipid metabolism, single photon emission computed tomography investigated brain perfusion.
Results:
Improvement of brain perfusion was observed after both monotherapy with bisoprolol and its combination with actovegin.
Conclusion:
Monotherapy with bisoprolol and bisoprolol combination with actovegin improved brain perfusion but the combination was more effective.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Peripheral Artery Disease III: Interprofessional Care
Ischemic Stroke l: Introduction
Atherosclerosis IV: Nursing Management
